In the most recent trading session, Morgan Stanley (MS) closed at $125.72, indicating a -0.02% shift from the previous trading day.
Shares of Morgan Stanley MS shed 0.02% to $125.72 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.43% to 5,881.63 and Dow ...
Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...
Jim Lacamp, Morgan Stanley Wealth Management senior vice president, joins CNBC's 'Money Movers' to discuss his outlook on the ...
The Morgan Stanley executive is retiring to run a foundation she started that aims to bring more young women into wealth ...
Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the National Institutes of Health and University of Pennsylvania ...
Morgan Stanley maintains a solid balance sheet, with assets reaching $1.26t and shareholder equity rising to $103.6b. Read ...
Morgan Stanley's strong Q3 performance saw a 17% non-interest revenue increase and a 37% rise in net income. Read more on the ...
In recent years, there has been a noted increase in the rates of chronic disease, as well as a growth in the number of ...
Despite Zinka Logistics strengths, Morgan Stanley is cautious about the stock’s valuation following its recent 105 percent run-up.
But these qualities are less prevalent here than at Morgan Stanley Advantage MPAIX, a tamer sibling to this strategy. The portfolio managers’ pursuit of unique business models often leads them ...
Shares of Morgan Stanley MS slipped 0.80% to $125.75 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.07% to 5,906.94 and Dow ...